FDA Approval of Carfilzomib in Myeloma and Sonidegib for Skin Cancer and more

onclivetv has 407 videos Subscribe Here

Description: Laura Jones report on FDA breakthrough designation for dabrafenib/trametinib in non-small cell lung cancer, legal movement regarding the first FDA-approved biosimilar, and reports on the FDA approval of carfilzomib in myeloma and sonidegib for skin cancer.
Shared By : onclivetv
Posted on : 08/10/15
Added : 4 years ago
Category : Multiple Myeloma